Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,897 shares at $148.24 ($281K) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Open-market sale of $281k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.50 | 369 | $54K | 19.4% |
| 2 | $147.50 | 369 | $54K | 19.4% |
| 3 | $148.24 | 519 | $77K | 27.4% |
| 4 | $148.24 | 519 | $77K | 27.4% |
| 5 | $149.03 | 121 | $18K | 6.4% |
| Total | $148.00 avg | 1,897 |
| $281K |
| 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |